Control Bionics Balance Sheet Health
Financial Health criteria checks 5/6
Control Bionics has a total shareholder equity of A$6.3M and total debt of A$517.1K, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are A$9.0M and A$2.8M respectively.
Key information
8.3%
Debt to equity ratio
AU$517.14k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$1.06m |
| Equity | AU$6.27m |
| Total liabilities | AU$2.76m |
| Total assets | AU$9.03m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CBL's short term assets (A$3.8M) exceed its short term liabilities (A$2.4M).
Long Term Liabilities: CBL's short term assets (A$3.8M) exceed its long term liabilities (A$356.5K).
Debt to Equity History and Analysis
Debt Level: CBL has more cash than its total debt.
Reducing Debt: CBL's debt to equity ratio has increased from 0% to 8.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CBL has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CBL is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.